Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update
Lisa DeTora, Dikran Toroser, Angela Sykes, Christine Vanderlinden, Fiona J. Plunkett, Trevor Lane, Eline E. Hanekamp, Laura Dormer, Faith DiBiasi, Daniel Bridges, Lise Baltzer, Leslie Citrome
Abstract
These updated Good Publication Practice (GPP) guidelines include recommendations for publishing company-sponsored biomedical research. The GPP guidelines apply to peer-reviewed or peer-oriented biomedical publications, such as manuscripts, meeting presentations, posters, and abstracts, as well as enhanced content, such as plain-language summaries. The current GPP guidelines incorporate guidance on ethics and transparency as well as the planning, development, review, and approval of biomedical publications and policies and procedures that describe these practices. Supplemental materials lay out processes for steering committees, publication plans, publication working groups, determining authorship, and documentation. Information about new topics, such as alliances and working with patients, has been included where appropriate within these supplemental materials. Incorporating the principles and best practices presented in these GPP guidelines will result in increased transparency and a firm ethical footing. This guidance is also intended to enable the compliant incorporation of new and emerging publication tools for the ethical publication of company-sponsored research.